Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 2;17(11):4617-4622.
doi: 10.1080/21645515.2021.1964310. Epub 2021 Sep 7.

Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine

Huakun Lv  1 , Xuejiao Pan  1 , Hui Liang  1 , Ying Wang  1 , Yu Hu  1
Affiliations

Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine

Huakun Lv et al. Hum Vaccin Immunother. .

Abstract

Objectives: To summarize reports to the national adverse event following immunization surveillance system (NAEFISS) following inactivated quadrivalent influenza vaccine (QIV) in Zhejiang province from 2018 to 2020.

Methods: We analyzed adverse events following immunization (AEFI) reports following QIV, with a comparison, with the AEFI reports following inactivated trivalent influenza vaccine (TIV). Reporting rates of AEFI were calculated by age, severity of AEFI, categories of AEFI, and reaction categories. The data mining algorithm used in this study was reporting odds ratio (ROR). A value of ROR‑1.96SE >1 (standard error [SE]) was considered as positive signal. These reporting rates between vaccine types were compared through chi-square tests.

Results: NAEFISS received 514 AEFI reports following QIV and 536 reports following TIV, with a reporting rate of 13.66/100,000 100,000 doses/100,000 doses (χ2 = 7.11, P> .05). Of the 514 reports following QIV, 410 were vaccine product-related reactions and 51 were severe AEFI. Fever/redness/induration was the most frequent clinical diagnosis of the QIV AEFI, with a reporting rate of 12.42/100,000 doses in the age group of 3-17 years, and 12.44/100,000 doses in the age group of ≥18 years. The positive signal of QIV AEFI was observed for the allergic rash and asthma/wheezing.

Conclusion: The present analysis did not identify any new/unexpected safety concerns. We suggested that NAEFISS continue to monitor the safety of QIV.

Keywords: Adverse events following immunization; inactivated quadrivalent influenza vaccine; inactivated trivalent influenza vaccine; surveillance; vaccination.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Lancet T. The L. World Flu Day: momentum from China for influenza control. Lancet. 2018;392(10158):1600. doi:10.1016/S0140-6736(18)32770-3. - DOI - PMC - PubMed
    1. Ellis SE, Coffey CS, Mitchel EF Jr., Dittus RS, Griffin MR.. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J Am Geriatr Soc. 2003;51:761–67. doi:10.1046/j.1365-2389.2003.51254.x. - DOI - PMC - PubMed
    1. Jansen AG, Sanders EA, Hoes AW, Van Loon AM, Hak E. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J. 2007;30:1158–66. doi:10.1183/09031936.00034407. - DOI - PubMed
    1. Peebles PJ, Dhara R, Brammer L, Fry AM, Finelli L. Influenza-associated mortality among children - United States: 2007-2008. Influenza Other Respi Viruses. 2011;5:25–31. doi:10.1111/j.1750-2659.2010.00166.x. - DOI - PMC - PubMed
    1. Sugaya N, Takeuchi Y. Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan. Clin Infect Dis. 2005;41:939–47. doi:10.1086/432938. - DOI - PubMed

Publication types